Supplements
Why Is My Triglycerides Still High?: Bioavailability, Stack Synergies, and Lab-Backed Dosing
You've cleaned up your diet, cut back on alcohol, and maybe even added a fish oil capsule — yet your triglycerides stubbornly refuse to budge. If your lipid panel keeps coming back with elevated triglycerides (above 150 mg/dL), the problem is rarely willpower; it's almost always a gap in strategy. Understanding why standard approaches fail — and what the clinical evidence actually supports — is the first step to finally moving that number.
Why Triglycerides Are Harder to Fix Than Your Doctor Implied
Elevated triglycerides — defined clinically as anything above 150 mg/dL, with "high" beginning at 200 mg/dL and "very high" at 500 mg/dL — are one of the most underestimated cardiovascular risk markers in routine blood work. Unlike LDL cholesterol, which has decades of statin data behind it, triglyceride elevation often doesn't get a clear treatment protocol until levels become severe. Yet high triglycerides are independently associated with increased cardiovascular risk, insulin resistance, and non-alcoholic fatty liver disease (NAFLD) (Miller et al., Journal of the American Heart Association 2011; PMID: 23926201).
So why is your triglycerides still high after months of effort? The answer almost always comes down to three overlapping factors: bioavailability of the interventions you're using, synergy gaps in your current stack, and dosing that falls short of what clinical trials actually used. Let's break each one down.
---
The Bioavailability Problem: Not All Omega-3s Are Equal
If you've been taking a standard fish oil capsule and waiting for results, you may be experiencing a classic bioavailability failure. The triglyceride-lowering effect of omega-3 fatty acids — specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) — is well-documented in clinical literature. A landmark meta-analysis of 79 randomized controlled trials found that omega-3 supplementation significantly reduced fasting triglycerides, with higher doses producing greater reductions (Bernasconi et al., Mayo Clinic Proceedings 2021; PMID: 33246583).
The problem is the dose and the form. Most over-the-counter fish oil capsules contain 300–500 mg of combined EPA/DHA per capsule. Clinical trials demonstrating meaningful triglyceride reduction — often in the range of 20–30% — typically used 2,000–4,000 mg of EPA/DHA daily. That's 4 to 12 standard capsules per day, which most people simply don't take consistently.
Beyond dose, the molecular form matters. Ethyl ester forms of omega-3 (the most common in supplements) are less bioavailable than triglyceride-form or re-esterified triglyceride forms, particularly when taken without a high-fat meal. A crossover trial demonstrated that re-esterified triglyceride omega-3s produced significantly higher plasma EPA and DHA levels compared to ethyl esters under fasted conditions (Dyerberg et al., Prostaglandins, Leukotrienes and Essential Fatty Acids 2010; PMID: 20638827).
Practical takeaway: If your fish oil isn't moving your triglycerides, check the EPA/DHA content on the label (not just the total fish oil weight), switch to a triglyceride-form product, and take it with your largest meal of the day.
---
Why Is My Fasting Glucose Still High?
This question belongs in a triglyceride conversation because fasting glucose and triglycerides are deeply interconnected through the same metabolic pathway. When fasting glucose remains elevated, it signals ongoing insulin resistance — and insulin resistance is one of the primary drivers of elevated triglyceride production in the liver. The liver converts excess glucose into very-low-density lipoprotein (VLDL) particles loaded with triglycerides, releasing them into circulation.
This is why treating elevated triglycerides without addressing glucose dysregulation is like bailing out a boat without plugging the hole. Research confirms that insulin-resistant individuals have significantly elevated hepatic VLDL secretion rates compared to insulin-sensitive controls (Adiels et al., Arteriosclerosis, Thrombosis, and Vascular Biology 2008; PMID: 17082491).
From a supplement standpoint, ingredients that improve insulin sensitivity can provide meaningful support for both fasting glucose and triglyceride levels. Berberine, for instance, has been shown in multiple trials to reduce fasting glucose by 15–25% and triglycerides by 10–18% simultaneously, likely through AMPK activation and improved hepatic lipid metabolism. If your fasting glucose and your triglycerides are both elevated, they are almost certainly part of the same metabolic dysfunction — and your intervention needs to address both at once.
---
Why Is My ApoB Still High?
Apolipoprotein B (ApoB) is a protein found on every atherogenic lipoprotein particle — LDL, VLDL, IDL, and Lp(a). When ApoB remains elevated after dietary changes, it usually means one of two things: your liver is still overproducing VLDL particles (which carries triglycerides), or your LDL clearance is impaired. Either way, elevated ApoB in the context of high triglycerides is a signal that your overall particle burden is not improving even if your LDL-C number looks acceptable.
This matters because standard lipid panels measure LDL cholesterol (LDL-C), not LDL particle number. You can have a "normal" LDL-C while carrying a dangerously high number of small, dense LDL particles — a pattern that correlates strongly with elevated ApoB and elevated triglycerides.
If your ApoB is still high, focus on reducing VLDL production at the source: dietary refined carbohydrates and added sugars are the dominant driver of hepatic triglyceride synthesis. Concurrently, consider that high-dose omega-3 therapy reduces VLDL secretion and improves ApoB particle distribution. A 12-week randomized controlled trial found that 4 g/day of EPA+DHA significantly reduced both triglycerides and ApoB compared to placebo (Davidson et al., Clinical Therapeutics 2007; PMID: 17577466).
If you're tracking both ApoB and triglycerides and neither is moving, the most common culprits are insufficient omega-3 dosing, continued high carbohydrate intake (especially fructose), or an underaddressed thyroid issue — since hypothyroidism reliably raises both markers.
---
Why Is My Lp(a) Still High?
It's worth addressing Lp(a) separately because it behaves very differently from standard triglyceride-related markers. Lipoprotein(a) — pronounced "L-P-little-a" — is a genetically determined lipid particle that is largely resistant to diet, exercise, and most common supplements. Unlike triglycerides, Lp(a) does not respond meaningfully to omega-3 supplementation or lifestyle changes for the majority of people.
If your Lp(a) is still high, this is almost certainly not a supplement bioavailability failure — it's a genetic reality that requires medical management, increasingly with emerging therapies like RNA-targeted agents (e.g., pelacarsen, olpasiran). What you can do from a lifestyle and supplement standpoint is aggressively manage the other cardiovascular risk markers that travel alongside elevated Lp(a): LDL-C, ApoB, inflammation (measured by hsCRP), and yes — triglycerides. Lowering your total cardiovascular risk burden is the most evidence-based strategy currently available for people with elevated Lp(a).
Consult your cardiologist or lipidologist if Lp(a) is above 50 mg/dL (or 125 nmol/L), particularly in combination with elevated triglycerides or family history of early heart disease.
---
Stack Synergies: What to Combine With Omega-3 for Greater Effect
Omega-3 fatty acids are the cornerstone of evidence-based triglyceride management, but they work better in context. Here are the ingredient combinations with the strongest clinical rationale:
| Ingredient | Mechanism | Clinical Dose | Effect on Triglycerides |
|---|---|---|---|
| Omega-3 (EPA/DHA) | Reduces hepatic VLDL synthesis | 2,000–4,000 mg/day | 20–30% reduction |
| Berberine | AMPK activation, reduces hepatic lipogenesis | 1,000–1,500 mg/day | 10–18% reduction |
| CoQ10/Ubiquinol | Mitochondrial efficiency, reduces oxidative stress on lipoproteins | 100–200 mg/day | Supportive/indirect |
| Vitamin D3 | Modulates insulin sensitivity and lipid metabolism | 2,000–5,000 IU/day | Supportive in deficient individuals |
| Magnesium | Cofactor for lipase activity and glucose regulation | 300–420 mg/day | Supportive |
The most powerful combination for someone with both elevated triglycerides and glucose dysregulation is high-dose EPA/DHA paired with berberine. These two work through complementary mechanisms — omega-3 at the level of hepatic VLDL production and berberine at the level of insulin sensitivity and AMPK signaling.
For individuals with elevated triglycerides and concurrent fatigue or oxidative stress markers, CoQ10 as ubiquinol (the reduced, more bioavailable form) provides mitochondrial support that complements lipid management by reducing the oxidative burden on circulating lipoproteins.
---
Why Is My A1C Still High?
Hemoglobin A1C reflects average blood glucose over approximately three months, and like fasting glucose, it is a direct upstream driver of triglyceride elevation. If your A1C is still high while you're trying to lower triglycerides, these two problems are almost certainly sharing the same root cause: chronic carbohydrate load, impaired insulin signaling, or both.
The clinical evidence for supplement support of A1C reduction points most strongly to berberine (comparable to metformin in some head-to-head trials for A1C reduction in type 2 diabetes) and, in deficient individuals, vitamin D3. A meta-analysis of 18 randomized controlled trials found that berberine significantly reduced A1C by an average of 0.71% compared to placebo (Yin et al., Metabolism 2008; PMID: 18442638).
If both your A1C and your triglycerides are elevated, you are almost certainly dealing with metabolic syndrome — a cluster of findings including abdominal obesity, high blood pressure, high fasting glucose, high triglycerides, and low HDL. Treating each marker in isolation is far less effective than addressing the underlying insulin resistance systemically.
---
What This Means for Your Formula
For people whose labs show persistently elevated triglycerides — especially alongside high fasting glucose, elevated ApoB, or high A1C — a data-driven supplement formula should be built around the specific pattern the labs reveal, not a generic heart health stack.
At Ones, the AI health practitioner analyzes your actual blood work and wearable data to identify which metabolic pathways are driving your specific lab pattern. For triglyceride elevation, relevant ingredients from the Ones catalog that may be included at clinical doses include:
- Omega-3 (EPA/DHA): Ones sources a high-concentration triglyceride-form omega-3 dosed to clinically meaningful levels based on your lab results, rather than the low-dose amounts common in standard multivitamins. For individuals with triglycerides above 200 mg/dL, the AI may prioritize this as a primary active in the formula.
- CoQ10/Ubiquinol at 200 mg: Ones includes ubiquinol (the active, reduced form) at 200 mg — the dose used in cardiovascular trials — rather than the 30–50 mg amounts common in many supplements. For individuals showing oxidative stress markers or taking statins (which deplete CoQ10), this can be a meaningful addition to a lipid-focused protocol.
- Heart Support Blend: Ones' proprietary Heart Support system blend is designed to complement individual actives for individuals with cardiovascular risk markers. Rather than replacing clinical-dose omega-3 or targeted actives, it supports the broader cardiovascular environment when indicated by your health history and lab findings.
The key advantage of a personalized approach is that your capsule formula is calibrated to your actual lab findings, not a one-size-fits-all heart health product. If your triglycerides are high because of glucose dysregulation, the formula addresses glucose. If it's driven by insufficient omega-3 status, the formula prioritizes EPA/DHA dose. That specificity is what generic supplements cannot offer.
Learn more about how omega-3 dosing affects cardiovascular markers and why insulin resistance drives multiple lipid abnormalities simultaneously.
---
Key Takeaways
- Triglycerides remain high most often because of insufficient omega-3 dose, poor bioavailability (ethyl ester vs. triglyceride form), or an unaddressed upstream driver like insulin resistance.
- High fasting glucose and high A1C are not separate problems from high triglycerides — they are the same metabolic dysfunction (insulin resistance driving hepatic VLDL overproduction).
- ApoB elevation alongside high triglycerides indicates high particle burden that LDL-C alone won't reveal; high-dose EPA/DHA addresses both markers.
- Lp(a) is largely genetically determined and does not respond to lifestyle or supplement intervention the way triglycerides do — manage surrounding risk factors aggressively instead.
- The most evidence-supported combination for triglyceride reduction is high-dose omega-3 (2,000–4,000 mg EPA/DHA daily) taken with a fat-containing meal, paired with metabolic support for insulin sensitivity.
- A personalized approach that maps your specific lab pattern to the right ingredients and doses — like Ones does using your blood work — outperforms generic heart health stacks for persistent dyslipidemia.
Always consult a qualified healthcare provider before making changes to your supplement regimen, particularly if you are managing diagnosed cardiovascular disease, diabetes, or are taking prescription lipid-lowering medications.